Trieu Vuong - Jun 28, 2023 Form 4 Insider Report for Oncotelic Therapeutics, Inc. (OTLC)

Role
CHAIRMAN AND CEO, Director, 10%+ Owner
Signature
/s/ Trieu, Vuong
Stock symbol
OTLC
Transactions as of
Jun 28, 2023
Transactions value $
$10,875
Form type
4
Date filed
6/30/2023, 09:25 AM
Previous filing
Jun 20, 2023
Next filing
Aug 27, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OTLC Common Stock Purchase $8.93K +425K +0.46% $0.02 92M Jun 29, 2023 Direct
transaction OTLC Common Stock Purchase $1.95K +75K +0.08% $0.03 91.6M Jun 28, 2023 Direct
holding OTLC Common Stock 16.8M Jun 28, 2023 By Autotelic, Inc.
holding OTLC Common Stock 6.87M Jun 28, 2023 By Spouse
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

On June 28, 2023, Dr. Trieu purchased 75,000 shares of Oncotelic Therapeutics, Inc. in his individual capacity, from the open market at a price of $0.026. Further, on June 29, 2023, Dr. Trieu purchased 425,000 shares of Oncotelic Therapeutics, Inc. in his individual capacity, from the open market at a price of $0.021.